DK1335728T3 - Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte - Google Patents

Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte

Info

Publication number
DK1335728T3
DK1335728T3 DK01989446T DK01989446T DK1335728T3 DK 1335728 T3 DK1335728 T3 DK 1335728T3 DK 01989446 T DK01989446 T DK 01989446T DK 01989446 T DK01989446 T DK 01989446T DK 1335728 T3 DK1335728 T3 DK 1335728T3
Authority
DK
Denmark
Prior art keywords
salts
pharmaceutical compositions
salmeterol
compositions based
tiotropium
Prior art date
Application number
DK01989446T
Other languages
English (en)
Inventor
Christel Schmelzer
Juergen Nagel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1335728T3 publication Critical patent/DK1335728T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01989446T 2000-11-13 2001-11-09 Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte DK1335728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056104A DE10056104A1 (de) 2000-11-13 2000-11-13 Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
PCT/EP2001/012962 WO2002038154A1 (de) 2000-11-13 2001-11-09 Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols

Publications (1)

Publication Number Publication Date
DK1335728T3 true DK1335728T3 (da) 2005-04-18

Family

ID=7663071

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01989446T DK1335728T3 (da) 2000-11-13 2001-11-09 Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte
DK04028508T DK1514546T3 (da) 2000-11-13 2001-11-09 Lægemiddelsammensætninger på basis af tiotropiumsalte og salte af salmeterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04028508T DK1514546T3 (da) 2000-11-13 2001-11-09 Lægemiddelsammensætninger på basis af tiotropiumsalte og salte af salmeterol

Country Status (32)

Country Link
EP (3) EP1808174A1 (da)
JP (2) JP4282322B2 (da)
KR (2) KR100886094B1 (da)
CN (1) CN1678318A (da)
AT (2) ATE362761T1 (da)
AU (3) AU2002227910B2 (da)
BG (1) BG107781A (da)
BR (1) BR0115226A (da)
CA (1) CA2429012A1 (da)
CY (1) CY1106774T1 (da)
CZ (1) CZ20031444A3 (da)
DE (3) DE10056104A1 (da)
DK (2) DK1335728T3 (da)
EA (1) EA007904B1 (da)
EC (1) ECSP034571A (da)
EE (1) EE200300228A (da)
ES (2) ES2240549T3 (da)
HR (1) HRP20030378A2 (da)
HU (1) HUP0301447A3 (da)
IL (2) IL155718A0 (da)
MX (1) MXPA03004164A (da)
NO (1) NO20032111L (da)
NZ (1) NZ526400A (da)
PL (1) PL205330B1 (da)
PT (2) PT1335728E (da)
RS (2) RS50286B (da)
SG (1) SG167657A1 (da)
SI (2) SI1335728T1 (da)
SK (2) SK286939B6 (da)
UA (1) UA74853C2 (da)
WO (1) WO2002038154A1 (da)
ZA (1) ZA200302921B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
MXPA04002401A (es) * 2001-09-14 2004-05-31 Boehringer Ingelheim Pharma Nuevos medicamentos para inhalacion.
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
DE10256080A1 (de) * 2002-11-29 2004-06-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropiumhaltige Arzneimittelkombination für die Inhalation
MXPA05006383A (es) * 2002-12-16 2005-08-29 Boehringer Ingelheim Pharma Formulaciones de soluciones de hidrofluorocarburo que contienen tiotropio.
UA83813C2 (ru) * 2002-12-20 2008-08-26 Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
MXPA06004697A (es) * 2003-11-03 2006-07-05 Boehringer Ingelheim Int Procedimiento para la preparacion de sales de tiotropio, sles de tiotropio, asi como formulaciones medicamentosas que las contienen.
AU2004285685B2 (en) * 2003-11-03 2011-03-24 Boehringer Ingelheim International Gmbh Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
ATE474601T1 (de) * 2004-05-31 2010-08-15 Almirall Sa Kombinationen mit antimuskarin-wirkstoffen und pde4-hemmern
BRPI0609295A2 (pt) 2005-05-02 2010-03-23 Boehringer Ingelheim Int formas cristalinas de brometo de tiotràpio, composiÇço farmacÊutica, uso e mÉtodo para preparar as mesmas
JP2009504603A (ja) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩とサルメテロールの塩とを組合せて投与する呼吸困難の治療方法
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20120220557A1 (en) * 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2819669B1 (de) * 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
TW201835041A (zh) 2017-02-17 2018-10-01 印度商托仁特生技有限公司 具β-腎上腺素促效劑及抗蕈毒活性化合物
WO2019142214A1 (en) * 2018-01-19 2019-07-25 Cipla Limited Pharmaceutical composition comprising tiotropium for inhalation
WO2020019953A1 (zh) * 2018-07-26 2020-01-30 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
CN116173025A (zh) * 2018-07-26 2023-05-30 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
WO2022119661A1 (en) * 2020-12-04 2022-06-09 Tygrus, LLC THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US12042514B2 (en) 2020-05-01 2024-07-23 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
JP2023552389A (ja) * 2020-12-04 2023-12-15 ティグラス，リミテッド ライアビリティ カンパニー 呼吸器疾病を有する患者に対処するための、少なくとも１種の病原体に対して活性な低ｐＨおよび低毒性を有する治療用材料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4570251B2 (ja) * 1998-07-24 2010-10-27 ヤゴテック アーゲー 医薬用エーロゾル製剤
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE19847971A1 (de) * 1998-10-17 1999-09-02 Schiering Verfahren und Einrichtung zur Verhinderung von Filterbränden (Staubfilter)
DE19847970A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähige Wirkstoff-Formulierung
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
DE19961300A1 (de) * 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator

Also Published As

Publication number Publication date
EE200300228A (et) 2003-10-15
ES2240549T3 (es) 2005-10-16
EA007904B1 (ru) 2007-02-27
EP1335728A1 (de) 2003-08-20
DE50105729D1 (de) 2005-04-28
PT1335728E (pt) 2005-05-31
NZ526400A (en) 2005-09-30
SI1335728T1 (en) 2005-08-31
SK286950B6 (sk) 2009-08-06
SK286939B6 (sk) 2009-07-06
ATE291428T1 (de) 2005-04-15
HUP0301447A3 (en) 2007-10-29
DK1514546T3 (da) 2007-09-24
KR20080079701A (ko) 2008-09-01
PT1514546E (pt) 2007-06-15
IL155718A (en) 2010-06-30
RS50286B (sr) 2009-09-08
CA2429012A1 (en) 2002-05-16
AU2007202303A1 (en) 2007-06-14
MXPA03004164A (es) 2005-08-16
KR100940752B1 (ko) 2010-02-11
ATE362761T1 (de) 2007-06-15
HRP20030378A2 (en) 2005-04-30
ECSP034571A (es) 2003-06-25
DE50112535D1 (de) 2007-07-05
JP4282594B2 (ja) 2009-06-24
ZA200302921B (en) 2004-04-19
RS20090105A (sr) 2009-07-15
EP1514546B1 (de) 2007-05-23
PL205330B1 (pl) 2010-04-30
ES2287629T3 (es) 2007-12-16
DE10056104A1 (de) 2002-05-23
NO20032111D0 (no) 2003-05-12
IL155718A0 (en) 2003-11-23
EA200300503A1 (ru) 2004-12-30
UA74853C2 (en) 2006-02-15
KR20030065509A (ko) 2003-08-06
SK7412003A3 (en) 2003-10-07
JP2005068163A (ja) 2005-03-17
SI1514546T1 (sl) 2007-10-31
JP2004513146A (ja) 2004-04-30
NO20032111L (no) 2003-07-08
EP1335728B1 (de) 2005-03-23
HUP0301447A2 (hu) 2003-10-28
EP1514546A1 (de) 2005-03-16
PL365989A1 (en) 2005-01-24
CN1678318A (zh) 2005-10-05
JP4282322B2 (ja) 2009-06-17
SG167657A1 (en) 2011-01-28
CZ20031444A3 (cs) 2003-08-13
CY1106774T1 (el) 2012-05-23
AU2791002A (en) 2002-05-21
KR100886094B1 (ko) 2009-02-27
AU2002227910B2 (en) 2007-03-01
BG107781A (bg) 2004-06-30
BR0115226A (pt) 2003-10-07
AU2007202303B2 (en) 2010-01-21
YU35503A (sh) 2006-05-25
WO2002038154A1 (de) 2002-05-16
EP1808174A1 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
DK1335728T3 (da) Lægemiddelsammensætninger på basis af tiotropiumsalte og salmeterolsalte
DK1178832T3 (da) Nye lægemiddelsammensætninger på basis af tiotropiumbromid og salmeterol
DK1524266T3 (da) Farmaceutisk sammensætning
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20105657L (fi) Farmaseuttisia koostumuksia
ITMI20010748A0 (it) Composizioni farmaceutiche
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
NO20025450L (no) Ny farmasöytisk sammensetning
EE04331B1 (et) Kiiresti lahustuv peroraalne ravimvorm
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
FI20011478L (fi) Farmaseuttinen koostumus
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
NO20026123L (no) Farmasöytiske sammensetninger
FI20022128A7 (fi) Farmaseuttinen koostumus
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE10291905D2 (de) Pharmazeutische Zusammensetzung
MXPA03001857A (es) Composicones medicinales.
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EE200200689A (et) Ravimkoostised
EP1413314A4 (en) MEDICAL COMPOSITIONS
FR2832313B1 (fr) Nouvelles compositions pharmaceutiques a visee anti-drepanocytaire